Download full report with analyst certification and important disclosures
Jul 31 2025, 07:50 IST/BST
DSM-firmenich (DSFIR) delivered an in-line EBITDA result for Q2-25. It is a mixed picture under the bonnet for Q2 with flat organic sales growth for Perfumery & Beauty (P&B) and 2% volume growth for Taste, Texture & Health (TTH) ex-synergies. Guidance language for FY25 is tweaked to reflect FX. We do not envisage any material change to our FY25 EBITDA forecast of €2,379m. The exit of Animal Nutrition & Health (ANH) is “advancing”.
Jul 31 2025, 07:50 IST/BST